Skip to main content
Top
Published in: European Journal of Nutrition 3/2013

01-04-2013 | Original Contribution

Effect of catechin/epicatechin dietary intake on endothelial dysfunction biomarkers and proinflammatory cytokines in aorta of hyperhomocysteinemic mice

Authors: Christophe Noll, Julie Lameth, Jean-Louis Paul, Nathalie Janel

Published in: European Journal of Nutrition | Issue 3/2013

Login to get access

Abstract

Purpose

Hyperhomocysteinemia is well recognized as an independent risk factor for the development of premature atherosclerosis. Atherosclerosis, however, may be prevented by polyphenols, potent antioxidant compounds with anti-atherogenic properties. Previously, we used cystathionine beta synthase-deficient mice [Cbs (±)] fed a high-methionine diet—a murine model of hyperhomocysteinemia—to show that daily intake of a red wine polyphenolic extract, mainly comprised of catechin and epicatechin, has a beneficial effect on aortic expression of endothelial dysfunction biomarkers and pro-inflammatory cytokines. The aim of the present study was to understand whether catechin and epicatechin, in purified forms, have anti-atherogenic effects in hyperhomocysteinemia.

Methods

Cbs (±) mice received 50 μg of catechin and/or epicatechin daily in drinking water for 1 month. Plasma homocysteine (Hcy) level and aortic expression of several endothelial dysfunction biomarkers (Vcam-1, Icam-1, E-selectin, and Lox-1) and pro-inflammatory cytokines (Tnf-α, Il-6) were assessed.

Results

We found that both catechin and epicatechin had a beneficial effect on plasma homocysteine levels and endothelial dysfunction biomarker expression; however, only catechin had a beneficial effect on pro-inflammatory cytokine expression. Further, when both polyphenols were given, a beneficial effect was observed only on pro-inflammatory cytokine expression.

Conclusions

Catechin seems to be a more potent anti-atherogenic compound than epicatechin in hyperhomocysteinemia and should be considered as a novel therapeutic approach against endothelial dysfunction induced by this condition.
Literature
1.
go back to reference Fortin LJ, Genest J (1995) Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 28(2):155–162CrossRef Fortin LJ, Genest J (1995) Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 28(2):155–162CrossRef
2.
go back to reference Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17(11):1410–1422CrossRef Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17(11):1410–1422CrossRef
3.
go back to reference Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 29(9):e45CrossRef Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 29(9):e45CrossRef
4.
go back to reference Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338(15):1042–1050CrossRef Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338(15):1042–1050CrossRef
5.
6.
go back to reference Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygård O, Vollset SE (2006) The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 136(6 Suppl):1731S–1740S Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygård O, Vollset SE (2006) The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 136(6 Suppl):1731S–1740S
7.
go back to reference Lentz SR (2005) Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3(8):1646–1654CrossRef Lentz SR (2005) Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3(8):1646–1654CrossRef
8.
go back to reference Noll C, Hamelet J, Matulewicz E, Paul J-L, Delabar J-M, Janel N (2009) Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. J Nutr Biochem 20(8):586–596CrossRef Noll C, Hamelet J, Matulewicz E, Paul J-L, Delabar J-M, Janel N (2009) Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. J Nutr Biochem 20(8):586–596CrossRef
9.
go back to reference Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92(5):1585–1589CrossRef Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92(5):1585–1589CrossRef
10.
go back to reference Hamelet J, Demuth K, Dairou J, Ledru A, Paul J-L, Dupret J-M, Delabar J-M, Rodrigues-Lima F, Janel N (2007) Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem Biophys Res Commun 355(1):221–227CrossRef Hamelet J, Demuth K, Dairou J, Ledru A, Paul J-L, Dupret J-M, Delabar J-M, Rodrigues-Lima F, Janel N (2007) Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem Biophys Res Commun 355(1):221–227CrossRef
11.
go back to reference Eberhardt RT, Forgione MA, Cap A et al (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Investiga 106(4):483–491CrossRef Eberhardt RT, Forgione MA, Cap A et al (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Investiga 106(4):483–491CrossRef
12.
go back to reference Li D, Liu L, Chen H, Sawamura T, Mehta JL (2003) LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arteriosclero Thrombo Vasc Biol 23(5):816–821CrossRef Li D, Liu L, Chen H, Sawamura T, Mehta JL (2003) LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arteriosclero Thrombo Vasc Biol 23(5):816–821CrossRef
13.
go back to reference Hammwöhner M, Ittenson A, Dierkes J, Bukowska A, Klein HU, Lendeckel U, Goette A (2007) Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med (Maywood) 232(4):581–589 Hammwöhner M, Ittenson A, Dierkes J, Bukowska A, Klein HU, Lendeckel U, Goette A (2007) Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med (Maywood) 232(4):581–589
14.
go back to reference Kassab A, Ajmi T, Issaoui M, Chaeib L, Miled A, Hammami M (2008) Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes. Ann Clin Biochem 45(Pt 5):476–480CrossRef Kassab A, Ajmi T, Issaoui M, Chaeib L, Miled A, Hammami M (2008) Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes. Ann Clin Biochem 45(Pt 5):476–480CrossRef
15.
go back to reference Rice-Evans C, Miller N, Paganga G (1997) Antioxidant properties of phenolic compounds. Trends Plant Sci 2(4):152–159CrossRef Rice-Evans C, Miller N, Paganga G (1997) Antioxidant properties of phenolic compounds. Trends Plant Sci 2(4):152–159CrossRef
16.
go back to reference Sies H (2010) Polyphenols and health: update and perspectives. Arch Biochem Biophys 501(1):2–5CrossRef Sies H (2010) Polyphenols and health: update and perspectives. Arch Biochem Biophys 501(1):2–5CrossRef
17.
go back to reference Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH (2009) LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 296(6):C1329–C1337CrossRef Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH (2009) LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 296(6):C1329–C1337CrossRef
18.
go back to reference Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45(4):287–306CrossRef Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45(4):287–306CrossRef
19.
go back to reference Stoclet J-C, Chataigneau T, Ndiaye M, Oak M-H, El Bedoui J, Chataigneau M, Schini-Kerth VB (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500(1–3):299–313CrossRef Stoclet J-C, Chataigneau T, Ndiaye M, Oak M-H, El Bedoui J, Chataigneau M, Schini-Kerth VB (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500(1–3):299–313CrossRef
20.
go back to reference Kaplan M, Aviram M (1999) Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37(8):777–787CrossRef Kaplan M, Aviram M (1999) Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37(8):777–787CrossRef
21.
go back to reference Kerkeni M, Addad F, Chauffert M, Chuniaud L, Miled A, Trivin F, Maaroufi K (2006) Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 39(8):821–825CrossRef Kerkeni M, Addad F, Chauffert M, Chuniaud L, Miled A, Trivin F, Maaroufi K (2006) Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 39(8):821–825CrossRef
22.
go back to reference Robert K, Chassé J-F, Santiard-Baron D, Vayssettes C, Chabli A, Aupetit J, Maeda N, Kamoun P, London J, Janel N (2003) Altered gene expression in liver from a murine model of hyperhomocysteinemia. J Biol Chem 278(34):31504–31511CrossRef Robert K, Chassé J-F, Santiard-Baron D, Vayssettes C, Chabli A, Aupetit J, Maeda N, Kamoun P, London J, Janel N (2003) Altered gene expression in liver from a murine model of hyperhomocysteinemia. J Biol Chem 278(34):31504–31511CrossRef
23.
go back to reference Janel N, Robert K, Chabert C, Ledru A, Gouédard C, Barouki R, Delabar J-M, Chassé J-F (2004) Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia. Thromb Haemost 92(1):221–222 Janel N, Robert K, Chabert C, Ledru A, Gouédard C, Barouki R, Delabar J-M, Chassé J-F (2004) Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia. Thromb Haemost 92(1):221–222
24.
go back to reference Gouédard C, Barouki R, Morel Y (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24(12):5209–5222CrossRef Gouédard C, Barouki R, Morel Y (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24(12):5209–5222CrossRef
25.
go back to reference Ou H-C, Song T-Y, Yeh Y-C et al (2010) EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol 108(6):1745–1756CrossRef Ou H-C, Song T-Y, Yeh Y-C et al (2010) EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol 108(6):1745–1756CrossRef
26.
go back to reference Foncea R, Carvajal C, Almarza C, Leighton F (2000) Endothelial cell oxidative stress and signal transduction. Biol Res 33(2):89–96CrossRef Foncea R, Carvajal C, Almarza C, Leighton F (2000) Endothelial cell oxidative stress and signal transduction. Biol Res 33(2):89–96CrossRef
27.
go back to reference Terra X, Valls J, Vitrac X et al (2007) Grape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signaling pathway. J Agric Food Chem 55(11):4357–4365CrossRef Terra X, Valls J, Vitrac X et al (2007) Grape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signaling pathway. J Agric Food Chem 55(11):4357–4365CrossRef
28.
go back to reference Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10(5):2327–2334 Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10(5):2327–2334
29.
go back to reference Raab T, Barron D, Vera FA, Crespy V, Oliveira M, Williamson G (2010) Catechin glucosides: occurrence, synthesis, and stability. J Agric Food Chem 58(4):2138–2149CrossRef Raab T, Barron D, Vera FA, Crespy V, Oliveira M, Williamson G (2010) Catechin glucosides: occurrence, synthesis, and stability. J Agric Food Chem 58(4):2138–2149CrossRef
30.
go back to reference Donovan JL, Bell JR, Kasim-Karakas S, German JB, Walzem RL, Hansen RJ, Waterhouse AL (1999) Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129(9):1662–1668 Donovan JL, Bell JR, Kasim-Karakas S, German JB, Walzem RL, Hansen RJ, Waterhouse AL (1999) Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129(9):1662–1668
31.
go back to reference Kutschera M, Engst W, Blaut M, Braune A (2011) Isolation of catechin-converting human intestinal bacteria. J Appl Microbiol 111(1):165–175CrossRef Kutschera M, Engst W, Blaut M, Braune A (2011) Isolation of catechin-converting human intestinal bacteria. J Appl Microbiol 111(1):165–175CrossRef
Metadata
Title
Effect of catechin/epicatechin dietary intake on endothelial dysfunction biomarkers and proinflammatory cytokines in aorta of hyperhomocysteinemic mice
Authors
Christophe Noll
Julie Lameth
Jean-Louis Paul
Nathalie Janel
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 3/2013
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0435-0

Other articles of this Issue 3/2013

European Journal of Nutrition 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.